PE-22-28

🔹 What is PE-22-28?

Class: Synthetic peptide fragment (derived from the neurotrophic protein Activity-Dependent Neuroprotective Protein – ADNP). Mechanism:

• Acts as a neuroprotective and neurotrophic fragment of ADNP.
• Regulates microtubule stability via interactions with tau protein, supporting neuronal structure and axonal transport.
• Enhances synaptic plasticity and learning processes.
• Provides anti-apoptotic and anti-inflammatory effects in neuronal cells.
• Has shown efficacy in reducing anxiety, depression, and cognitive decline in preclinical models.

Primary focus:

• Neuroprotection in aging and neurodegenerative diseases.
• Cognitive enhancement through synaptic repair and neuroplasticity.
• Mood regulation with anxiolytic and antidepressant potential.
• Potential role in autism spectrum disorder and neurodevelopmental conditions.

---

🔹 Oral Dosage Range:

• 200 µg – 1 mg daily (anecdotal and early research use).
• Sublingual delivery often preferred for absorption.

Notes:

• Like its parent ADNP fragment (NAP/CP201), designed for stability in non-injectable forms.

---

🔹 Injectable / Subcutaneous Dosage Range:

• 100–500 µg SC daily or 2–3x/week (research use).
• Oral/sublingual is generally emphasized over injectable routes.

---

🔹 Cycle Length

• Neuroprotection and cognitive effects: 8–12+ weeks.
• Wellness use: ongoing low-dose administration is considered reasonable in biohacking communities.

---

🔹 Optimal Dosing Window

• Morning or midday → enhances learning, focus, and mood during active hours.
• Avoid late-evening use to reduce the risk of sleep disruption.

---

✅ Educational Integration Example Example protocol: 500 µg PE-22-28 sublingual, once daily, for 8 weeks. Paired with: NAD⁺ 100 mg SC 2–3x/week + Semax 500 µg intranasal (as needed). Rationale: Provides a foundation for neuroprotection while amplifying focus and plasticity.

---

🔹 Stacking Strategy (Educational / Complementary) Because PE-22-28 enhances microtubule stability, synaptic repair, and mood regulation, complementary stacks emphasize BDNF support, mitochondrial resilience, and cognitive enhancement: 🔸 Neuroplasticity & Synaptic Repair

• Dihexa → drives synaptogenesis, complementary to PE-22-28’s structural support.
• Semax / Selank → enhance BDNF release and balance mood/anxiety.
• Lion’s Mane → supports NGF-driven structural repair.

🔸 Mitochondrial & Energy Support

• NAD⁺ / NMN / NR → maintain ATP and neuronal repair capacity.
• MOTS-c / SS-31 → improve mitochondrial function, reducing neurodegenerative stress.

🔸 Neuroprotection & Mood Regulation

• Methylene Blue → redox support and neuroprotection.
• Noopept → cholinergic and memory-enhancing synergy.
• Low-dose Ketamine (research/clinical setting) → overlaps in mood regulation and plasticity.

Rationale: PE-22-28 provides a neurostructural foundation, and stacking builds out metabolic resilience, synaptic growth, and emotional stability.

---

⚠️ Safety Notes

• Human trial data is still very limited — most evidence comes from preclinical studies.
• Anecdotal reports suggest it is well tolerated at low doses.
• Overactivation of neuroplasticity pathways may cause anxiety, overstimulation, or disrupted sleep in sensitive users.
• Long-term safety in healthy populations is not yet established.

Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.